Get the Stockscreener App
340.25
0.23%
-0.80
After Hours:
340.25
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $340.25, with a volume of 730.43K.
It is down -0.23% in the last 24 hours and down -7.77% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$341.05
Open:
$340.3
24h Volume:
730.43K
Relative Volume:
0.52
Market Cap:
$66.01B
Revenue:
$321.33B
Net Income/Loss:
$1.57B
P/E Ratio:
42.79
EPS:
7.9518
Net Cash Flow:
$3.21B
1W Performance:
+0.06%
1M Performance:
-7.77%
6M Performance:
+13.64%
1Y Performance:
+49.94%
1-Day Range:
$339.19
$342.11
1-Week Range:
$336.41
$343.67
52-Week Range:
$223.92
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
340.25 | 66.16B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
830.42 | 102.23B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
207.38 | 49.49B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
76.44 | 8.96B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.43 | 768.83M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Why Cencora Inc. stock attracts HNW investorsReal-Time Stock Alerts & Free Dashboard to Track Market Momentum - bollywoodhelpline.com
Valley National Advisers Inc. Decreases Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Bets Big on Oncology Platform in $5 Billion OneOncology Deal - MyChesCo
Cencora to Acquire TPG’s Equity Stake in OneOncology, Strengthening Specialty Care Platform - Digital Health News
Burney Co. Cuts Stock Position in Cencora, Inc. $COR - MarketBeat
Exchange Traded Concepts LLC Buys 7,924 Shares of Cencora, Inc. $COR - MarketBeat
Jim Cramer says “I like Cencora a lot” but notes “Cardinal Health’s got them all beat” - MSN
These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026 - TradingView — Track All Markets
Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks - Finviz
Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora - The Globe and Mail
Patton Fund Management Inc. Trims Position in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Coho Partners Ltd. - MarketBeat
Insider Sell Alert: Silvana Battaglia Sells Shares of Cencora In - GuruFocus
Cencora (NYSE:COR) CEO Robert Mauch Sells 5,096 Shares - MarketBeat
Cencora (NYSE:COR) EVP Elizabeth Campbell Sells 3,351 Shares - MarketBeat
Silvana Battaglia Sells 1,677 Shares of Cencora (NYSE:COR) Stock - MarketBeat
Cencora CEO Mauch sells $1.75m in shares By Investing.com - Investing.com South Africa
Cencora CEO Mauch sells $1.75m in shares - Investing.com
Cencora Insider Sold Shares Worth $1,750,221, According to a Recent SEC Filing - marketscreener.com
Don't Ignore The Insider Selling In Cencora - 富途牛牛
Trust Point Inc. Invests $1.32 Million in Cencora, Inc. $COR - MarketBeat
Wedge Capital Management L L P NC Sells 21,403 Shares of Cencora, Inc. $COR - MarketBeat
Voya Investment Management LLC Trims Position in Cencora, Inc. $COR - MarketBeat
BDF Gestion Buys Shares of 12,508 Cencora, Inc. $COR - MarketBeat
Is Cencora Inc. stock considered safe havenMarket Volume Report & Real-Time Sentiment Analysis - ulpravda.ru
Insider Sell Alert: Lazarus Krikorian Sells Shares of Cencora In - GuruFocus
Market Moves: Is Cencora Inc. stock a safe haven asset2025 Volume Leaders & Daily Technical Stock Forecast Reports - Улправда
Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" - Finviz
VP Campbell Files To Sell 3,351 Of Cencora Inc [COR] - TradingView — Track All Markets
[144] Cencora, Inc. SEC Filing - Stock Titan
Cencora Insider Sold Shares Worth $1,383,580, According to a Recent SEC Filing - marketscreener.com
[Form 4] Cencora, Inc. Insider Trading Activity - Stock Titan
Cencora SVP & Chief Accounting Officer Sells 4,031 Shares - TradingView — Track All Markets
Cencora (COR) CFO exercises options, uses 26,952 shares for taxes - Stock Titan
CFO Cleary Jr Acquires 18,202 Of Cencora Inc [COR] - TradingView — Track All Markets
Taxation With Representation: Baker Botts, Morgan Lewis - Law360
Jim Cramer Says “I like Cencora A Lot” But Notes “Cardinal Health’s Got Them All Beat” - Insider Monkey
Cencora to Acquire OneOncology to Expand Community Oncology Solutions - Finviz
COR (COR) insider to sell 1,677 common shares on NYSE - Stock Titan
Is Cencora Inc. stock a contrarian buyMarket Sentiment Review & Reliable Momentum Entry Alerts - DonanımHaber
Breakout Watch: How Cencora Inc. stock compares to industry benchmarksJuly 2025 Reactions & Daily Profit Maximizing Tips - ulpravda.ru
How Cencora Inc. stock performs in rate cut cyclesPortfolio Value Summary & Reliable Intraday Trade Alerts - DonanımHaber
Why Cencora Inc. stock is rated strong buyQuarterly Growth Report & Fast Moving Stock Watchlists - DonanımHaber
Texas Permanent School Fund Corp Has $3.63 Million Holdings in Cencora, Inc. $COR - MarketBeat
Is Cencora Inc. stock ready for breakout2025 Performance Recap & Technical Pattern Recognition Alerts - DonanımHaber
Osaic Holdings Inc. Buys 9,171 Shares of Cencora, Inc. $COR - MarketBeat
Why Cencora Inc. stock is recommended by analystsJuly 2025 Earnings & Technical Confirmation Trade Alerts - DonanımHaber
Czech National Bank Purchases 7,075 Shares of Cencora, Inc. $COR - MarketBeat
Why Cencora Inc. stock attracts high net worth investors2025 Price Momentum & Short-Term High Return Strategies - DonanımHaber
How geopolitical tensions affect Cencora Inc. stockShare Buyback & Consistent Income Trade Ideas - DonanımHaber
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):